| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |